The UK's National Institute for Health and Clinical Excellence (NICE) issued an Interventional Procedure Guidance recommending treatment of benign prostate hyperplasia with Procept BioRobotics Corp.'s AquaBeam robotic Aquablation system as an alternative to other surgical techniques.
"The evidence on transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia raises no major safety concerns," NICE explains in the recommendation. However, the agency...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?